Gerresheimer
Gerresheimer is a prominent global partner to the pharmaceutical and healthcare industries, specializing in the production of specialty glass and plastic products that enhance health and well-being. With approximately 10,000 employees, the company operates manufacturing facilities across Europe, North America, South America, and Asia, generating around EUR 1.4 billion in revenue. Its diverse product portfolio includes pharmaceutical packaging solutions and drug delivery devices, such as insulin pens, inhalers, refillable syringes, injection vials, ampoules, and various containers for both liquid and solid medications. Additionally, Gerresheimer produces packaging for the cosmetics sector and emphasizes innovations in medical technology through its advanced technologies segment. The majority of its revenue is derived from the European market, particularly Germany, reflecting its strong presence in the region.
Top Stages
4 past transactions
Bormioli Pharma
Acquisition in 2024
Bormioli Pharma is a manufacturer specializing in primary packaging solutions for the pharmaceutical industry. The company provides a diverse array of childproof and tamper-evident caps and bottles made from materials such as PET, PE, PP, and glass fibers. These packaging products are designed to ensure the safe and efficient storage of medications, protecting them from deterioration and extending their stability. Additionally, Bormioli Pharma's offerings facilitate accurate dosing, contributing to the overall safety and reliability of pharmaceutical products.
Adamant Health
Seed Round in 2022
Adamant Health is a technology company focused on enhancing the care of Parkinson's disease through innovative measurement and analysis tools. Drawing on over 15 years of academic research from the University of Eastern Finland, the company has developed advanced devices that utilize a combination of motion sensing and electromyography to measure and analyze symptoms associated with the disease. By providing clinicians with detailed insights into a patient's condition over several days, Adamant Health enables the optimization of treatment plans. Additionally, the data collected serves as valuable real-world evidence for pharmaceutical companies, aiding in clinical and post-market studies and supporting personalized medication strategies. This approach allows for better understanding and management of Parkinson's disease in both clinical and home settings.
Sensile Medical
Acquisition in 2018
Sensile Medical AG is a Swiss company specializing in the development of nanoliter-based medical devices for glucose monitoring and micro drug delivery systems. Founded in 2004 and based in Hägendorf, it focuses on creating innovative liquid drug delivery devices that enhance patient care and improve quality of life. Sensile Medical's technology offers a customizable platform for safe and efficient drug administration, featuring both reusable and disposable devices to minimize waste and optimize therapy costs. The company has established strategic partnerships with organizations such as scPharmaceuticals LLC, Sanofi, and Verily, which support its mission to advance liquid delivery systems. As of July 2018, Sensile Medical operates as a subsidiary of Gerresheimer AG, further solidifying its position in the healthcare market.
Centor
Acquisition in 2015
Centor specializes in the manufacture of plastic vials and closures that are used by pharmacies to accurately deliver prescribed medications to patients. The company is dedicated to producing regulatory compliant prescription containers that prioritize safety, aiming to prevent accidental drug ingestions while ensuring ease of use for consumers. Centor adheres to the standards set by the U.S. Consumer Product Safety Commission for child-resistant packaging, reflecting its commitment to both safety and functionality in the pharmaceutical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.